Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia. An Independent, Pragmatic, Multicentre, Parallel-Group, Superiority Trial.

Trial Profile

Randomized Evaluation of the Effectiveness of Clozapine and Aripiprazole Versus Clozapine and Haloperidol in the Treatment of Schizophrenia. An Independent, Pragmatic, Multicentre, Parallel-Group, Superiority Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Jun 2014

At a glance

  • Drugs Aripiprazole (Primary) ; Clozapine; Haloperidol
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms CHAT
  • Most Recent Events

    • 19 Apr 2011 Results published in the Journal of Clinical Psychopharmacology.
    • 19 Apr 2011 Status changed from active, no longer recruiting to completed, based on results published in the Journal of Clinial Psychopharmacology.
    • 17 Feb 2009 Planned end date added to 1 Dec 2009 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top